101 related articles for article (PubMed ID: 2106823)
1. Variation in plasma apolipoprotein A-1 and B concentrations following myocardial infarction.
Shephard MD; Hester J; Walmsley RN; White GH
Ann Clin Biochem; 1990 Jan; 27 ( Pt 1)():9-14. PubMed ID: 2106823
[TBL] [Abstract][Full Text] [Related]
2. Serum amyloid A protein, apolipoprotein A-I, and apolipoprotein B during the course of acute myocardial infarction.
Maury CP; Tötterman KJ; Gref CG; Ehnholm C
J Clin Pathol; 1988 Dec; 41(12):1263-8. PubMed ID: 3147288
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein(a) and apolipoproteins B and A-I after acute myocardial infarction.
Husain M; Armstrong PW; Connelly PW; Hegele RA
Can J Cardiol; 1995 Mar; 11(3):206-10. PubMed ID: 7889438
[TBL] [Abstract][Full Text] [Related]
4. [Serum apolipoprotein AI, B levels in patients with coronary diseases].
He Y
Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Aug; 18(4):217-9, 254. PubMed ID: 2128269
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein A-I and apolipoprotein B in survivors of myocardial infarction.
Karira K; Baseer A
J Pak Med Assoc; 1987 Feb; 37(2):44-7. PubMed ID: 3106663
[No Abstract] [Full Text] [Related]
6. [Plasma levels of apolipoproteins A-I, B and H in men after myocardial infarct].
Choluj B; Votruba T; Sedlák F; Klestincová J; Matyska L
Cas Lek Cesk; 1984 Nov; 123(47):1433-6. PubMed ID: 6439411
[No Abstract] [Full Text] [Related]
7. [Lipoprotein and apolipoprotein AI, B levels in the blood of male survivors of acute myocardial infarction].
Huang TG
Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Jun; 17(3):149-52. PubMed ID: 2513177
[No Abstract] [Full Text] [Related]
8. The relation of apolipoproteins A-I and B in children to parental myocardial infarction.
Freedman DS; Srinivasan SR; Shear CL; Franklin FA; Webber LS; Berenson GS
N Engl J Med; 1986 Sep; 315(12):721-6. PubMed ID: 3092050
[TBL] [Abstract][Full Text] [Related]
9. Von Willebrand factor, plasminogen activator inhibitor-1 and C-reactive protein are markers of thrombolytic efficacy in acute myocardial infarction.
Andreotti F; Hackett DR; Haider AW; Roncaglioni MC; Davies GJ; Beacham JL; Kluft C; Maseri A
Thromb Haemost; 1992 Dec; 68(6):678-82. PubMed ID: 1287882
[TBL] [Abstract][Full Text] [Related]
10. The long-term effect of alprenolol on plasma apolipoproteins A-I and B.
Gerdes LU; Jürgensen HJ; Groot PH; Faergeman O
Acta Med Scand; 1988; 223(5):419-22. PubMed ID: 3132028
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.
Stampfer MJ; Sacks FM; Salvini S; Willett WC; Hennekens CH
N Engl J Med; 1991 Aug; 325(6):373-81. PubMed ID: 2062328
[TBL] [Abstract][Full Text] [Related]
12. The relation of apolipoproteins A-I and B in children to myocardial infarction in parents.
van Stiphout WA; Hofman A
N Engl J Med; 1987 Feb; 316(9):548-9. PubMed ID: 3100955
[No Abstract] [Full Text] [Related]
13. Evaluation of apolipoproteins A1 and B in survivors of myocardial infarction.
Jadhav PP; Taskar AP; Taskar SP; Darne RD
J Assoc Physicians India; 1994 Sep; 42(9):703-5. PubMed ID: 7883664
[TBL] [Abstract][Full Text] [Related]
14. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR
Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044
[TBL] [Abstract][Full Text] [Related]
15. [Assays of apolipoproteins A and B as atherogenicity factors in aged patients at hospitals].
Hofmann D; Sebbane G; Orellana V; Maury S; Kirkacharian M; Tofis V; Nguyen P
Ann Med Interne (Paris); 1989; 140(1):36-40. PubMed ID: 2660651
[TBL] [Abstract][Full Text] [Related]
16. Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.
Kim HK; Chang SA; Choi EK; Kim YJ; Kim HS; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS
Int J Cardiol; 2005 Jun; 101(3):435-40. PubMed ID: 15907412
[TBL] [Abstract][Full Text] [Related]
17. Changes in plasma C-reactive protein and hemostatic factors prior to and after a first myocardial infarction with a median follow-up time of 8 years.
Thøgersen AM; Nilsson TK; Weinehall L; Boman K; Eliasson M; Hallmans G; Jansson JH
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):340-6. PubMed ID: 19357504
[TBL] [Abstract][Full Text] [Related]
18. Lipid-related genes and myocardial infarction in 4685 cases and 3460 controls: discrepancies between genotype, blood lipid concentrations, and coronary disease risk.
Keavney B; Palmer A; Parish S; Clark S; Youngman L; Danesh J; McKenzie C; Delépine M; Lathrop M; Peto R; Collins R;
Int J Epidemiol; 2004 Oct; 33(5):1002-13. PubMed ID: 15256516
[TBL] [Abstract][Full Text] [Related]
19. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.
Walldius G; Jungner I; Holme I; Aastveit AH; Kolar W; Steiner E
Lancet; 2001 Dec; 358(9298):2026-33. PubMed ID: 11755609
[TBL] [Abstract][Full Text] [Related]
20. Simplified turbidimetric determination of apolipoproteins A-I, A-II and B using a microtitre method.
Sandkamp M; Tambyrajah B; Schriewer H; Assmann G
J Clin Chem Clin Biochem; 1988 Nov; 26(11):685-8. PubMed ID: 3148681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
